Evidence map›Paper›PMID 33784991›Full record

ArticleBMC musculoskeletal disorders2021

Effectiveness of early switching from intravenous to oral antibiotic therapy in Staphylococcus aureus prosthetic bone and joint or orthopedic metalware-associated infections.

Hélène Boclé, Jean-Philippe Lavigne, Nicolas Cellier, Julien Crouzet, Pascal Kouyoumdjian, Albert Sotto, Paul Loubet

Open access · goldAbstract read
In one paragraph

Article in BMC musculoskeletal disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. DACBiomedicines · 2025
    Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hélène BocléDepartment of Infectious and Tropical Diseases, CHU Nîmes, University of Montpellier, Nîmes, France.
Jean-Philippe LavigneVirulence Bactérienne et Maladies Infectieuses, Inserm U1407, Université de Montpellier, Nîmes, France.
Nicolas CellierDepartment of Orthopedic and Trauma Surgery, CHU Nîmes, University of Montpellier, Nîmes, France.
Julien CrouzetDepartment of Infectious and Tropical Diseases, CHU Nîmes, University of Montpellier, Nîmes, France.
Pascal KouyoumdjianDepartment of Orthopedic and Trauma Surgery, CHU Nîmes, University of Montpellier, Nîmes, France.
Albert SottoDepartment of Infectious and Tropical Diseases, CHU Nîmes, University of Montpellier, Nîmes, France.
Paul LoubetDepartment of Infectious and Tropical Diseases, CHU Nîmes, University of Montpellier, Nîmes, France. paul.loubet@chu-nimes.fr.ORCID https://orcid.org/0000-0002-1218-9432
Université de Montpellier · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe optimal duration of intravenous antibiotic therapy in Staphylococcus aureus prosthetic bone and joint infection has not been established. The objective of this study was to compare the effect of early and late intravenous-to-oral antibiotic switch on treatment failure. PATIENTS AND

methodsWe retrospectively analyzed all adult cases of S. aureus prosthetic bone and joint or orthopedic metalware-associated infection between January 2008 and December 2015 in a French university hospital. The primary outcome was treatment failure defined as the recurrence of S. aureus prosthetic bone and joint or orthopedic metalware-associated infection at any time during or after the first line of medical and surgical treatment within 2 years of follow-up. A Cox model was created to assess risk factors for treatment failure.

resultsAmong the 140 patients included, mean age was 60.4 years (SD 20.2), and 66% were male (n = 92). Most infections were due to methicillin-susceptible S. aureus (n = 113, 81%). The mean duration of intravenous antibiotic treatment was 4.1 days (SD 4.6). The majority of patients (119, 85%) had ≤5 days of intravenous therapy. Twelve patients (8.5%) experienced treatment failure. Methicillin-resistant S. aureus infections (HR 11.1; 95% CI 1.5-111.1; p = 0.02), obesity (BMI > 30 kg/m

conclusionThere was a low treatment failure rate in patients with S. aureus prosthetic bone and joint or orthopedic metalware-associated infection with early oral switch from intravenous to oral antibiotic therapy.

Indexed as

Methicillin-Resistant Staphylococcus aureusProsthesis-Related InfectionsStaphylococcal InfectionsAdultAnti-Bacterial AgentsFemaleHumansMaleMiddle AgedRetrospective StudiesStaphylococcus aureusAnti-Bacterial AgentsIntravenous antibiotic treatmentOral antibiotic treatmentProsthetic bone and joint infectionsStaphylococcus aureus

Identifiers

PMID33784991
PMCPMC8008605
OpenAlexW3143752201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.